Bio-Techne Corp at JPMorgan Healthcare Conference Transcript
Good morning and welcome to the second day of the JPMorgan Healthcare conference here in San Francisco. My name is Tayvon Wilson. I'm an associate in the healthcare group based in New York. I'm pleased to introduce and and host the biotechnni team here, Kim Calderman, the CEO, and Jim Kimel to my right, who's the CFO.
Kim.
Thank you. Oh, thank you, Tavon. It's always a pleasure being here. And it's exciting to be here for the 3rd time, for my, for myself.
We have a very excited 2026 ahead of us, and I'm really looking forward to going through the presentation, which will start with an overview of the company, and then followed by a double click on the strategy going forward. But before I get into the data, I would like to draw your attention to our safe harbor statement, which you can find on our website www.biotechnique.com under the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
